Seattle, WA -- (SBWIRE) -- 03/23/2017 -- The report "Fetal Monitoring Market by Product (Ultrasound, Electronic Fetal Monitors, Electrodes, Doppler, Uterine Contraction, Telemetry), Portability, Method (Invasive), Application (Antepartum, Intrapartum), End User (Hospital, Clinics) - Forecast to 2019", provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the fetal monitoring market along with the estimates and forecasts of the revenue and market share analysis.
Download PDF brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=35700261
Browse 188 market data tables and 55 figures spread through 270 pages and in-depth TOC on "Fetal Monitoring Market by Product (Ultrasound, Electronic Fetal Monitors, Electrodes, Doppler, Uterine Contraction, Telemetry), Portability, Method (Invasive), Application (Antepartum, Intrapartum), End User (Hospital, Clinics) - Forecast to 2019"
Early buyers will receive 10% customization on reports.
The global fetal monitoring market is expected to reach $2,346.4 million by 2019 from $1,688.7 million in 2014, at a CAGR of 6.8% from 2014 to 2019.
The report segments this market based on products, portability, methods, applications, and end users. Among various end users, the hospitals segment is expected to account for the largest share of the market and is expected to grow at the highest CAGR from 2014 to 2019. The high growth in this segment can be attributed to the rising rate of maternal mortality and fetal birth defects, and increasing number of initiatives taken by government organizations for improving prenatal care.
Based on geography, the global fetal monitoring market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this geographic segment is driven by factors such as increasing government support for enhanced maternal facilities and rising company investments for the development of new products.
Key players in the fetal monitoring market include Analogic Corporation (U.S.), ArjoHuntleigh, Inc. (U.S.), Covidien PLC (U.S.), FUJIFILM SonoSite, Inc. (U.S.), GE Healthcare (U.K.), Natus Medical Incorporated (U.S.), Neoventa Medical (Sweden), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), and Spacelabs Healthcare Inc. (U.S.).
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. For more information, please visit www.marketsandmarkets.com